Cập nhật về Viêm Khớp Phản Ứng Sau Nhiễm Trùng Liên Cầu: Tổng Quan Về Một Bệnh Bị Quên

• Shulman ST, Dale JB. Group A Streptococcal virulence: new Lessons. J Pediatric Infect Dis Soc. 2019;8:160–1 Of importance for understanding Sterptococcal virulence factors. Maness DL, Martin M, Mitchell G. Poststreptococcal illness: recognition and management. AFP. 2018;97:517–22. Bertola EA, Simonetti GD, Del Giorno R, Giannini O, Fossali EF, Meoli M, et al. Extrarenal immune-mediated disorders linked with acute poststreptococcal glomerulonephritis: a systematic review. Clin Rev Allergy Immunol. 2019;57:294–302. Friedberg CK. Editorial. Circulation. American Heart Association. 1959;19:161–4. • Deighton C. Beta haemolytic streptococci and reactive arthritis in adults. Ann Rheum Dis. 1993;52:475–82 Of importance as one of the first manuscripts to state that PSRA is an unique entity. • Shulman ST, Ayoub EM. Poststreptococcal reactive arthritis. Curr Opin Rheumatol. 2002;14:562–5 Of importance as the most commonly used diagnostic criteria for PSRA. Lehman TJ, Edelheit BS. Clinical trials for post-streptococcal reactive arthritis. Curr Rheumatol Rep. 2001;3:363–4. van der Helm-van Mil AHM. Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered. Curr Opin Rheumatol. 2010;22:437–42. Chun C, Kingsbury DJ. Poststreptococcal reactive arthritis: diagnostic challenges. Perm J. 2019;23:18.304. https://doi.org/10.7812/TPP/18.304. • Fraser H, Gallacher D, Achana F, Court R, Taylor-Phillips S, Nduka C, et al. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation. Health Technol Assess. 2020;24:1–232 Of importance delineating the role of rapid tests for streptococcal infection. Dias C, Selmi C. The challenge of treating orphan disease. Clin Rev Allergy Immunol. 2014;47:259–63. Uziel Y, Perl L, Barash J, Hashkes PJ. Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever. Pediatr Rheumatol Online J. 2011;9:32. García-Kutzbach A, Chacón-Súchite J, García-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol. 2018;37:869–74. Ahmed S, Ayoub EM, Scornik JC, Wang CY, She JX. Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum. 1998;41:1096–102. Simonini G, Porfirio B, Cimaz R, Calabri GB, Giani T, Falcini F. Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in Italian children. Semin Arthritis Rheum. 2004;34:553–8. • Dagan A, Dahan S, Shemer A, Langevitz P, Hellou T, Davidson T, et al. Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series. Clin Rheumatol. 2019;38:2367–72 Of importance showing possible overlap between PSRA and psoriatic spondyloarthritis. De Jesús-Gil C, Sans-de San Nicolás L, Ruiz-Romeu E, Ferran M, Soria-Martinez L, Chiriac A, et al. Specific IgA and CLA+ T-cell IL-17 response to Streptococcus pyogenes in Psoriasis. J Invest Dermatol. 2020;140:1364–1370.e1. Sato S, Uejima Y, Suganuma E, Takano T, Kawano Y. A retrospective study: acute rheumatic fever and post-streptococcal reactive arthritis in Japan. Allergol Int. 2017;66:617–20. • Nishibukuro M, Tsutsumi N, Chiyotanda M, Hijikata T, Morichi S, Go S, et al. Poststreptococcal reactive arthritis in Japan. J Infect Chemother. 2018;24:531–7 Of importance to understand recent trends of PSRA. • Padhan P, Danda D. Clinical spectrum of post-streptococcal reactive arthritis (PSRA) revisited: juvenile versus adult-onset disease. Int J Rheum Dis. 2019;22:750–1 Of importance to understand recent trends of PSRA. • Muşetescu AE, Florea M, ForŢofoiu MC, Bumbea AM, Tudorancea AD, Criveanu C, et al. Streptococcal tonsillitis related reactive arthritis—clinical, ultrasound imaging and immunohistochemical study. Rom J Morphol Embryol. 2017;58:801–7 Of importance to understand recent trends of PSRA. Barash J, Mashiach E, Navon-Elkan P, Berkun Y, Harel L, Tauber T, et al. Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever. J Pediatr. 2008;153:696–9. Haydardedeoğlu FE, Tutkak H, Köse K, Düzgün N. HLA-DR alleles in patients with post-streptococcal reactive arthritis. Rheumatol Int. 2006;27:111–3. Visser H, Speyer I, Ozcan B, Breedveld FC, van Ogtrop ML, Hazes JM. The diagnostic value of streptococcal serology in early arthritis: a prospective cohort study. Rheumatology (Oxford). 2000;39:1351–6. Jansen TL, Janssen M, Traksel R, de Jong AJ. A clinical and serological comparison of group A versus non-group A streptococcal reactive arthritis and throat culture negative cases of post-streptococcal reactive arthritis. Ann Rheum Dis. 1999;58:410–4. Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med. 1999;245:261–7. Hilário MOE, Terreri MTSLRA. Rheumatic fever and post-streptococcal arthritis. Best Pract Res Clin Rheumatol. 2002;16:481–94. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301. Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2020;16:32–50. • Cunningham MW. Molecular Mimicry, Autoimmunity and infection: the cross-reactive antigens of group A streptococci and their sequelae. Microbiol Spectr [Internet]. 2019 [cited 2020 Jul 12];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684244/. of importance in understanding pathogenesis of immune manifestations of Streptococci. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511. Delunardo F, Scalzi V, Capozzi A, Camerini S, Misasi R, Pierdominici M, et al. Streptococcal-vimentin cross-reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease. Clin Exp Immunol. 2013;173:419–29. Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proceedings of the National Academy of Sciences of the United States of America. Natl Acad Sci. 1992;89:1320. Bright PD, Mayosi BM, Martin WJ. An immunological perspective on rheumatic heart disease pathogenesis: more questions than answers. Heart. 2016;102:1527–32. Roberts S, Kosanke S, Dunn ST, Jankelow D, Duran CMG, Cunningham MW. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. The Journal of Infectious Diseases Oxford University Press. 2001;183:507–11. Tandon R, Sharma M, Chandrashekhar Y, Kotb M, Yacoub MH, Narula J. Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol. 2013;10:171–7. • de Crombrugghe G, Baroux N, Botteaux A, Moreland NJ, Williamson DA, Steer AC, et al. The limitations of the rheumatogenic concept for group A Streptococcus: systematic review and genetic analysis. Clin Infect Dis. 2020;70:1453–60 Of importance in estimating our limitations in understanding the immune pathogenesis. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87:811–22. Rush CM, Govan BL, Sikder S, Williams NL, Ketheesan N. Animal models to investigate the pathogenesis of rheumatic heart disease. Front Pediatr. 2014;2:116. Binstadt BA, Hebert JL, Ortiz-Lopez A, Bronson R, Benoist C, Mathis D. The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. Proceedings of the National Academy of Sciences of the United States of America. National Academy of Sciences. 2009;106:16758. Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. Pathak H, Marshall T. Post-streptococcal reactive arthritis: where are we now. BMJ Case Rep. 2016;2016:bcr2016215552. Sarakbi HA, Hammoudeh M, Kanjar I, Al-Emadi S, Mahdy S, Siam A. Poststreptococcal reactive arthritis and the association with tendonitis, tenosynovitis, and enthesitis. J Clin Rheumatol. 2010;16:3–6. Perl L, Kvint I, Matitiau A, Levi A, Barash J, Uziel Y. Late cardiac assessment in children diagnosed with post-streptococcal reactive arthritis: a long term study. Clin Exp Rheumatol. 2015;33:578–82. Simonini G, Taddio A, Cimaz R. No evidence yet to change American Heart Association recommendations for poststreptococcal reactive arthritis: comment on the article by van Bemmel et al. Arthritis Rheum. 2009;60:3516–8 author reply 3518-3519. van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TWJ, Bax JJ, et al. No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum. 2009;60:987–93. Riise ØR, Lee A, Cvancarova M, Handeland KS, Wathne K-O, Nakstad B, et al. Recent-onset childhood arthritis—association with Streptococcus pyogenes in a population-based study. Rheumatology (Oxford). 2008;47:1006–11. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics. 1998;101:86–8. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279–82. Massell BF, Honikman LH, Amezcua J. Rheumatic fever following streptococcal vaccination. Report of three cases. JAMA. 1969;207:1115–9. Thorsteinsson B, Geirsson AJ, Krogh NS, Gudbjornsson B, ICEBIO. Outcomes and safety of TNF inhibitors in reactive arthritis: a nationwide experience from Iceland. J Rheumatol. 2020.